Intermediate CAG repeat length in the HTT gene and comorbidity – The SHAPE Study (Swedish-Huntingtin-Alleles-and-PhenotypE)
Objective: To 1) determine the distribution of CAG repeats of the Huntingtin gene in a Swedish general population sample, 2) explore the phenotype caused by…A global survey on speech language therapists’ awareness to Huntington’s disease
Objective: To investigate the awareness and knowledge of speech and language therapists (SLTs) on Huntington’s disease (HD) worldwide, and to explore the clinical practice and…Multimodal characterization of the visual network in Huntington’s disease
Objective: To examine the relationship between structural organization, functional processing and task performance of the visual system in a cohort of Huntington’s disease (HD) gene-mutation…Burden of Huntington’s disease in the US: Analysis of an insured population
Objective: To describe the healthcare resource utilization (HRU) in Huntington’s disease (HD) in private (commercial) and public (Medicare and Medicaid) insurance plans in the US.…Impact of caring for patients with Huntington’s disease on work status
Objective: To describe changes in the employment status of family members caring for a person with Huntington’s disease (HD) in the US and Europe. Background:…Patient and physician perspectives on the care and assistance needs in Huntington’s disease
Objective: To describe the assistance needs of people with Huntington’s disease (HD) across different countries. Background: HD is a genetic, neurodegenerative and ultimately fatal disease…Huntington’s Disease Protein Huntingtin Associates with its own mRNA
Objective: To investigate how Htt might affect RNA metabolism we set out to purify and analyze RNA associated with Htt. Background: The Huntington's disease (HD)…Mobility Impairments in Huntington’s Disease due to Cognitive Dysfunction
Objective: This study examined the relationships of mobility, motor and cognitive function measures at baseline, and of mobility and cognitive measures over four years Background:…Factors underlying reduced aerobic capacity in Huntington disease
Objective: Examine factors underlying aerobic capacity in prodromal and manifest Huntington disease (HD) and matched controls Background: HD results in motor impairments, weight loss, muscle…Brain MRI Volume Changes after 12 months laquinimod treatment of Huntington disease (LEGATO-HD)
Objective: To explore the effect of laquinimod on brain volume in patients with Huntington Disease (HD). Background: Volume loss in caudate and other brain regions…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.